2022 Full Event Guide
See what you missed...
Having issues downloading? Click here
"I think an in-depth discussion of potential avenues to mitigate the safety concerns upon AAV gene transfer imposed by immune responses to the vector or the transgene product are of wide interest to not only those who conduct clinical trials but also recipients of AAV gene transfer."
Hildegund Ertl
Professor
The Wistar Institute